BNR - Burning Rock Biotech GAAP EPS of -$0.18 revenue of $20.2M
2023-08-31 02:15:02 ET
- Burning Rock Biotech press release ( NASDAQ: BNR ): Q2 GAAP EPS of -$0.18.
- Revenue of $20.2M (+11.8% Y/Y).
- Cash, cash equivalents, restricted cash and short-term investments were $101.1 million as of June 30, 2023.
For further details see:
Burning Rock Biotech GAAP EPS of -$0.18, revenue of $20.2M